NCT07140081 - A Research Study to Evaluate BLX-0871 in Healthy Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions

Normal Healthy Adults

Interventions

DRUG

BLX-0871

BLX-0871 Single or Multiple doses administered orally as a tablet

DRUG

Placebo

Participants will receive matching placebo of BLX-0871 for each of the oral cohorts.

Trial Locations (1)

Nucleus Network St Kilda Road, Melbourne